Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T62449 | Target Info | |||
Target Name | Checkpoint kinase-1 (CHK1) | ||||
Synonyms | Serine/threonine-protein kinase Chk1; Chk1; Cell cycle checkpoint kinase; CHK1 checkpoint homolog | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CHEK1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Staurosporine | Ligand Info | |||
Canonical SMILES | CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC | ||||
InChI | 1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 | ||||
InChIKey | HKSZLNNOFSGOKW-FYTWVXJKSA-N | ||||
PubChem Compound ID | 44259 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7AKO Crystal structure of CHK1 kinase domain in complex with a CLASPIN phosphopeptide | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | Yes | [1] |
PDB Sequence |
AVPFVEDWRL
11 VQTLGEGAYG21 EVQLAVNRVT31 EEAVAVKIVD41 MKRAVDCPEN51 IKKEICINKM 61 LNHENVVKFY71 GHRREGNIQY81 LFLEYCSGGE91 LFDRIEPDIG101 MPEPDAQRFF 111 HQLMAGVVYL121 HGIGITHRDI131 KPENLLLDER141 DNLKISDFGL151 ATVFRYNNRE 161 RLLNKMCGTL171 PYVAPELLKR181 REFHAEPVDV191 WSCGIVLTAM201 LAGELPWDQP 211 SDSCQEYSDW221 KEKKTYLNPW231 KKIDSAPLAL241 LHKILVENPS251 ARITIPDIKK 261 DRWYNKPLKK271
|
|||||
|
||||||
PDB ID: 5OOR Structure of CHK1 10-pt. mutant complex with staurosporine | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | Yes | [2] |
PDB Sequence |
VPFVEDWDLV
12 QTLGEGAYGE22 VQLAVNRVTE32 EAVAVKIVDM42 NIKKEICILK60 MLNHENVIKF 70 YGHRREGNIQ80 YLFMELASGG90 SLFDRIEPDI100 GMPEPDAQRF110 FHQLMAGVVY 120 LHGIGITHRD130 IKPHNLLLDE140 RDNLKIADYS150 LATVFRYNNR160 ERLLNKMCGT 170 LPYVAPELLK180 RREFHAEPVD190 VWSCGIVLTA200 MLAGELPWDQ210 PSDSCQEYSD 220 WKEKKTYLNP230 WKKIDSAPLA240 LLHKILVENP250 SARITIPDIK260 KDRWYNKPLK 270 KGAKRPRVTS280 GGV
|
|||||
|
||||||
PDB ID: 1NVR The Complex Structure Of Checkpoint Kinase Chk1/Staurosporine | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [3] |
PDB Sequence |
VPFVEDWDLV
12 QTLGEGAYGE22 VQLAVNRVTE32 EAVAVKIVDM42 KNIKKEICIN59 KMLNHENVVK 69 FYGHRREGNI79 QYLFLEYCSG89 GELFDRIEPD99 IGMPEPDAQR109 FFHQLMAGVV 119 YLHGIGITHR129 DIKPENLLLD139 ERDNLKISDF149 GLATVFRYNN159 RERLLNKMCG 169 TLPYVAPELL179 KRREFHAEPV189 DVWSCGIVLT199 AMLAGELPWD209 QPSDSCQEYS 219 DWKEKKTYLN229 PWKKIDSAPL239 ALLHKILVEN249 PSARITIPDI259 KKDRWYNKPL 269 KKGA
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural basis for recruitment of the CHK1 DNA damage kinase by the CLASPIN scaffold protein. Structure. 2021 Jun 3;29(6):531-539.e3. | ||||
REF 2 | Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1). J Med Chem. 2017 Nov 9;60(21):8945-8962. | ||||
REF 3 | Structural basis for Chk1 inhibition by UCN-01. J Biol Chem. 2002 Nov 29;277(48):46609-15. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.